Provided by Tiger Trade Technology Pte. Ltd.

FibroBiologics

1.73
-0.0300-1.70%
Post-market: 1.730.00000.00%16:43 EDT
Volume:83.60K
Turnover:143.35K
Market Cap:11.52M
PE:-0.36
High:1.80
Open:1.73
Low:1.67
Close:1.76
52wk High:12.40
52wk Low:0.6201
Shares:6.66M
Float Shares:5.84M
Volume Ratio:0.27
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7656
EPS(LYR):-8.3501
ROE:-660.08%
ROA:-95.77%
PB:2.48
PE(LYR):-0.21

Loading ...

Fibrobiologics - Expects Cost Savings by Eliminating Additional Vial Manufacturing

THOMSON REUTERS
·
Jul 07

Fibrobiologics - Expects Sufficient Cywc628 Supply to Complete Dfu Clinical Trial

THOMSON REUTERS
·
Jul 07

Fibrobiologics Completes Manufacturing of Third Batch of Cywc628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

THOMSON REUTERS
·
Jul 07

FibroBiologics Secures New Private Placement Financing

TIPRANKS
·
Jun 30

Fibrobiologics Closes Private Placement Priced at USD 0.735 Per Share, Raises USD 3 Million Upfront

Reuters
·
Jun 30

Fibrobiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-market Under NASDAQ Rules

THOMSON REUTERS
·
Jun 30

FibroBiologics announces $9M private placement priced at-the-market

TIPRANKS
·
Jun 26

Fibrobiologics Prices Unregistered $3 Million Share Private Placement at $0.735 Per Share

Reuters
·
Jun 26

Press Release: Fibrobiologics Announces up to $9.0 Million Private Placement Priced At-the-market Under NASDAQ Rules

Dow Jones
·
Jun 26

FibroBiologics Shareholders Approve New 2026 Equity Plan

TIPRANKS
·
Jun 24

FibroBiologics shareholders approve 2026 equity incentive plan at annual meeting

Reuters
·
Jun 24

Fibrobiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

THOMSON REUTERS
·
Jun 22

FibroBiologics gets USPTO notice of allowance for topical fibroblast spheroid wound-healing patent application

Reuters
·
Jun 22

FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

GlobeNewswire
·
Jun 22

FibroBiologics doses first patients in CYWC628 clinical trial

TIPRANKS
·
Jun 16

FibroBiologics doses first patients in Phase 1/2 trial of CYWC628 for diabetic foot ulcers

Reuters
·
Jun 16

Fibrobiologics Inc: Continues to Advance Manufacturing of Cywc628 to Support Ongoing Trial Activity

THOMSON REUTERS
·
Jun 16

Fibrobiologics - to Ship Second Gmp Run of Cywc628 to Australia Week of June 15, 2026

THOMSON REUTERS
·
Jun 16

Fibrobiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of Cywc628 for the Treatment of Diabetic Foot Ulcers

THOMSON REUTERS
·
Jun 16

Fibrobiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating Cywc628 for the Treatment of Diabetic Foot Ulcers

THOMSON REUTERS
·
Jun 03